GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Clinical trials for GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for shrinking stomach tumors before surgery
Disease control OngoingThis study tests whether adding two drugs (camrelizumab and apatinib) to standard chemotherapy before surgery can help shrink tumors in people with advanced stomach or gastroesophageal junction cancer. About 80 participants will receive the treatment before their planned surgery.…
Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New drug combo shows promise in stomach cancer battle
Disease control OngoingThis study tests whether adding the immunotherapy drug camrelizumab to standard chemotherapy and apatinib can improve outcomes for people with stomach or gastroesophageal junction cancer. About 580 adults with locally advanced but removable tumors will receive the treatment befor…
Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC